TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8935119

Group type: EXPERIMENTAL
Intervention: Ritipenem acoxil (RIPM-AC) 200 mg, t.i.d. for 14 days
Number of subjects: 202

Group type: COMPARATOR
Intervention: Cefotiam hexetil (CTM-HE) 400 mg, t.i.d. for 14 days
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Ritipenem acoxil (RIPM-AC)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Cefotiam hexetil (CTM-HE)
Number of subjects: 202
Study: 1935294

Group type: EXPERIMENTAL
Intervention: Postural drainage and forced expiration technique (PD + FET)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Positive expiratory pressure (PEP-mask) and forced expiration technique (PEP + FET)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control
Number of subjects: 10
Study: 6129141

Group type: EXPERIMENTAL
Intervention: Prizidilol 150 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Prizidilol 300 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Prizidilol 600 mg
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 29326421

Group type: EXPERIMENTAL
Intervention: 250 ml 1000 IU vitamin D3-fortified milk daily for 9 weeks
Number of subjects: 102

Group type: COMPARATOR
Intervention: 250 ml unfortified milk daily for 9 weeks
Number of subjects: 102
Study: 26852887

Group type: EXPERIMENTAL
Intervention: Immediate mobilisation
Number of subjects: 43

Group type: COMPARATOR
Intervention: Dorsal wrist cast for 2 weeks
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 43
Study: 25454120

Group type: EXPERIMENTAL
Intervention: Short-term therapy
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Long-term therapy
Number of subjects: 251
Study: 23292054

Group type: EXPERIMENTAL
Intervention: Expectant care
Number of subjects: 160

Group type: COMPARATOR
Intervention: ERPC under general anaesthesia
Number of subjects: 160
Study: 20409359

Group type: EXPERIMENTAL
Intervention: School-based intervention focusing on nutrition education and increasing fruit and vegetable intake; implemented in collaboration with teachers.
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: School-based intervention focusing on nutrition education; implemented in collaboration with teachers.
Number of subjects: 106

Group type: COMPARATOR
Intervention: Control schools with no intervention.
Number of subjects: 106
Study: 17646746

Group type: EXPERIMENTAL
Intervention: Aspheric IOL
Number of subjects: 24

Group type: COMPARATOR
Intervention: Spherical IOL
Number of subjects: 24
Study: 16128648

Group type: EXPERIMENTAL
Intervention: Intravenous morphine titration
Number of subjects: 39

Group type: COMPARATOR
Intervention: Subcutaneous morphine titration
Number of subjects: 39
Study: 12209866

Group type: EXPERIMENTAL
Intervention: Stress Inoculation Training with Prolonged Exposure (SITPE)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Eye Movement Desensitization and Reprocessing (EMDR)
Number of subjects: 24
Study: 9867157

Group type: EXPERIMENTAL
Intervention: Gallium-67 renal scan positive group
Number of subjects: 47

Group type: COMPARATOR
Intervention: Gallium-67 renal scan negative group
Number of subjects: 47
Study: 7638802

Group type: EXPERIMENTAL
Intervention: Magnetic stimulation of the phrenic nerves
Number of subjects: 16
Study: 2765808

Group type: EXPERIMENTAL
Intervention: Human thrombin (0.2-0.3 ml, 100-150 units per injection) plus 5% ethanolamine oleate
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Human thrombin plus 5% ethanolamine oleate
Number of subjects: 50

Group type: COMPARATOR
Intervention: Thrombin - group (control)
Number of subjects: 50
Study: 1093756

Group type: EXPERIMENTAL
Intervention: Propranolol (640 mg daily for two months)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Diuretic induced salt depletion
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Propranolol after salt depletion
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Propranolol in patients with moderate renal failure
Number of subjects: 38

Group type: COMPARATOR
Intervention: Salt depletion by furosemide in renal failure patients
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Propranolol after salt depletion in renal failure patients
Number of subjects: 38
Study: 31724530

Group type: EXPERIMENTAL
Intervention: R2PHF 0.0625 mg
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: R2PHF 0.25 mg
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: R2PHF 0.50 mg
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: R2PHF 1.0 mg
Number of subjects: 31

Group type: COMPARATOR
Intervention: PHC 1.0 mg
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 27528707

Group type: EXPERIMENTAL
Intervention: Targeted nurse‐led case finding for CVD prevention
Number of subjects: 2926

Group type: COMPARATOR
Intervention: Unexposed period (no intervention)
Number of subjects: 2926
Study: 24970876

Group type: EXPERIMENTAL
Intervention: Azathioprine after 3-6 months of cyclophosphamide
Number of subjects: 144

Group type: COMPARATOR
Intervention: Cyclophosphamide after 12 months
Number of subjects: 144
Study: 22382150

Group type: EXPERIMENTAL
Intervention: Circumcision
Number of subjects: 2787

Group type: COMPARATOR
Intervention: HSV-2
Number of subjects: 2787

Group type: COMPARATOR
Intervention: GUD
Number of subjects: 2787
Study: 20724982

Group type: EXPERIMENTAL
Intervention: Reamberin (energy corrector antioxidants) included in standard treatment schemes
Number of subjects: 61
Study: 18417417

Group type: EXPERIMENTAL
Intervention: Tailored feedback letters based on the transtheoretical model
Number of subjects: 1044
Study: 15947324

Group type: EXPERIMENTAL
Intervention: C-Flex therapy
Number of subjects: 89

Group type: COMPARATOR
Intervention: CPAP therapy
Number of subjects: 89
Study: 12577187

Group type: EXPERIMENTAL
Intervention: Alendronate (part of the Fracture Intervention Trial)
Number of subjects: 909

Group type: COMPARATOR
Intervention: Hip fractures
Number of subjects: 909

Group type: COMPARATOR
Intervention: Lumbar vertebral fractures
Number of subjects: 909

Group type: COMPARATOR
Intervention: Other fractures (thoracic vertebrae, humerus, distal forearm, ankle, and foot)
Number of subjects: 909
Study: 9642851

Group type: EXPERIMENTAL
Intervention: Recognition task for safe vs neutral faces in panic patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Recognition task for critical vs accepting faces in panic patients
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 0
Study: 1884726

Group type: EXPERIMENTAL
Intervention: Spironolactone beta-cyclodextrin complex (100 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Micronised spironolactone powder (100 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Spironolactone tablets (Aldactone) (100 mg)
Number of subjects: 8
Study: 6638605

Group type: EXPERIMENTAL
Intervention: Lidoflazine therapy
Number of subjects: 6
Study: 31621274

Group type: EXPERIMENTAL
Intervention: Nutritional supplement melatonin (ME-group) for two months
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Nutritional supplements melatonin, tryptophan, and vitamin B6 (MET-group) for two months
Number of subjects: 34
Study: 31032543

Group type: EXPERIMENTAL
Intervention: Alfuzosin
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Mental stress (Stroop test)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Mental stress (Arithmetic test)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Mental relaxation
Number of subjects: 74
Study: 28174138

Group type: EXPERIMENTAL
Intervention: Soft model foods
Number of subjects: 58
Study: 26809561

Group type: EXPERIMENTAL
Intervention: Advocacy program delivered by a local NGO to 22 companies
Number of subjects: 45

Group type: COMPARATOR
Intervention: No specific intervention for 23 control companies
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Advocacy program
Number of subjects: 45
Study: 25174356

Group type: EXPERIMENTAL
Intervention: THAO-Child Health Program (community based intervention)
Number of subjects: 2249
Study: 22280521

Group type: EXPERIMENTAL
Intervention: Turkish immigrants needing interpretation when using health services (n = 108, 36.5%)
Number of subjects: 416

Group type: EXPERIMENTAL
Intervention: Older age, non-homeownership, low socioeconomic class, poor access to health services, being ill, poor community integration, and being obese
Number of subjects: 416

Group type: EXPERIMENTAL
Intervention: Low income and poor community integration
Number of subjects: 416
Study: 20851232

Group type: EXPERIMENTAL
Intervention: Levonorgestrel administered in two doses of 0.75 mg given 12 h apart
Number of subjects: 3022

Group type: COMPARATOR
Intervention: Levonorgestrel administered in a single dose of 1.5 mg
Number of subjects: 3022

Group type: EXPERIMENTAL
Intervention: Both regimens
Number of subjects: 3022
Study: 17931935

Group type: EXPERIMENTAL
Intervention: Satelec ET 40 ultrasonic tip at power 1
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Satelec ET 40 ultrasonic tip at power 5
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: CPR 5 ultrasonic tip at power 1
Number of subjects: 30

Group type: COMPARATOR
Intervention: Ultrasonic vibration without coolant
Number of subjects: 30
Study: 15684446

Group type: EXPERIMENTAL
Intervention: Kangaroo mother care (KMC)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Conventional method of care (CMC)
Number of subjects: 89
Study: 12564822

Group type: EXPERIMENTAL
Intervention: Biweekly parenting classes and weekly meetings with a social worker
Number of subjects: 60

Group type: COMPARATOR
Intervention: Weekly parenting classes focusing on learning how to meet the infants' needs
Number of subjects: 60
Study: 9830286

Group type: EXPERIMENTAL
Intervention: PVP-iodine
Number of subjects: 100

Group type: COMPARATOR
Intervention: Topical broad-spectrum antibiotics
Number of subjects: 100
Study: 7634175

Group type: EXPERIMENTAL
Intervention: Chronotherapy for cancer drugs; specific dosage and duration not mentioned.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chronotherapy scheduling method; specific details not mentioned.
Number of subjects: 0
Study: 2285091

Group type: EXPERIMENTAL
Intervention: Intraarticular bupivacaine injection at the conclusion of knee arthroscopy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no bupivacaine)
Number of subjects: 0
Study: 7396657

Group type: EXPERIMENTAL
Intervention: Amitriptyline and short-term interpersonal psychotherapy (IPT)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Short-term interpersonal psychotherapy (IPT)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Amitriptyline (tricyclic medication)
Number of subjects: 81
Study: 31782629

Group type: EXPERIMENTAL
Intervention: Initial postnatal care within 24 hours
Number of subjects: 700

Group type: EXPERIMENTAL
Intervention: Initial postnatal care within 7 days
Number of subjects: 700

Group type: EXPERIMENTAL
Intervention: Initial postnatal care within 14 days
Number of subjects: 700

Group type: EXPERIMENTAL
Intervention: Health education by RECO (Relais Cmunataure)
Number of subjects: 700

Group type: EXPERIMENTAL
Intervention: Hand washing
Number of subjects: 700

Group type: EXPERIMENTAL
Intervention: Malaria prevention
Number of subjects: 700
Study: 27566991

Group type: EXPERIMENTAL
Intervention: CFA bifurcation location
Number of subjects: 989

Group type: EXPERIMENTAL
Intervention: IEA origin
Number of subjects: 989

Group type: EXPERIMENTAL
Intervention: CFA access recommendation
Number of subjects: 989

Group type: EXPERIMENTAL
Intervention: Predictive value of demographics
Number of subjects: 989
Study: 27647060

Group type: EXPERIMENTAL
Intervention: Sustained Care
Number of subjects: 1357

Group type: COMPARATOR
Intervention: Standard Care
Number of subjects: 1357
Study: 24656963

Group type: EXPERIMENTAL
Intervention: Carbohydrate-matching insulin bolus (8.30 U [7.50 U-11.50 U])
Number of subjects: 12

Group type: COMPARATOR
Intervention: Weight-dependent insulin bolus (0.047 U/kg; 3.45 U [2.95 U-3.75 U])
Number of subjects: 12
Study: 22657838

Group type: EXPERIMENTAL
Intervention: Sodium caseinate (Cas, 29 g)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: TG‐treated sodium caseinate (Cas‐TG, 29 g)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Whey protein (Wh, 30 g)
Number of subjects: 13
Study: 19570808

Group type: EXPERIMENTAL
Intervention: Left ventricular pacing (LVP, n=15, pacing duration: 4.3+/‐2.6 years)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Right ventricular pacing (RVP, n=10, pacing duration: 7.9+/‐2.9 years)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (15 healthy children)
Number of subjects: 25
Study: 17501955

Group type: EXPERIMENTAL
Intervention: Imiquimod 5% cream applied once daily 3 days per week for 4 weeks
Number of subjects: 259

Group type: COMPARATOR
Intervention: Vehicle control applied three times a week for 4 weeks
Number of subjects: 259
Study: 14745754

Group type: EXPERIMENTAL
Intervention: 0.2 mmol/kg bw gadobutrol
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 0.1 mmol/kg bw gadobutrol
Number of subjects: 36

Group type: COMPARATOR
Intervention: 0.2 mmol/kg bw Gd-DTPA
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 0.2 mmol/kg bw gadobutrol (increased flip angle of 40 degrees)
Number of subjects: 36

Group type: COMPARATOR
Intervention: 0.2 mmol/kg bw Gd-DTPA (in volunteers)
Number of subjects: 36
Study: 11431614

Group type: EXPERIMENTAL
Intervention: Migav‐Ladach method (ML)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pfannenstiel technique
Number of subjects: 0
Study: 9699780

Group type: EXPERIMENTAL
Intervention: Early or prophylactic interventions in childhood asthma
Number of subjects: 0

Group type: COMPARATOR
Intervention: Randomization of individuals
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Repeated measures of outcome (lung function)
Number of subjects: 0
Study: 8050544

Group type: EXPERIMENTAL
Intervention: Hyperreactivity defined as PD20 ≤ 12.25 mumol
Number of subjects: 2415

Group type: COMPARATOR
Intervention: Females
Number of subjects: 2415

Group type: COMPARATOR
Intervention: Current smokers
Number of subjects: 2415

Group type: COMPARATOR
Intervention: Atopy (measured by skin wheal response)
Number of subjects: 2415

Group type: COMPARATOR
Intervention: Older age groups (60-70 years)
Number of subjects: 2415

Group type: EXPERIMENTAL
Intervention: Absolute FEV1
Number of subjects: 2415

Group type: EXPERIMENTAL
Intervention: FEV1 % predicted
Number of subjects: 2415

Group type: EXPERIMENTAL
Intervention: FEV1 % FVC
Number of subjects: 2415
Study: 2378705

Group type: EXPERIMENTAL
Intervention: Ultrafresh (Faulding)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 40
Study: 342217

Group type: EXPERIMENTAL
Intervention: Cimetidine 300 mg q.i.d.
Number of subjects: 71

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71
Study: 30193971

Group type: EXPERIMENTAL
Intervention: Laparoscopic ovarian cystectomy
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Laparoscopic cyst deroofing
Number of subjects: 122
Study: 24621459

Group type: EXPERIMENTAL
Intervention: Behavioral parent training program
Number of subjects: 85

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 85
Study: 26542495

Group type: EXPERIMENTAL
Intervention: Radial access
Number of subjects: 1035
Study: 23916874

Group type: EXPERIMENTAL
Intervention: 100-µm PVA particles (group A)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 200-µm PVA particles (group B)
Number of subjects: 80
Study: 21856483

Group type: EXPERIMENTAL
Intervention: Enoxaparin
Number of subjects: 910

Group type: COMPARATOR
Intervention: Unfractionated heparin
Number of subjects: 910
Study: 19188327

Group type: EXPERIMENTAL
Intervention: Endovascular revascularization (angioplasty-first approach), n = 76
Number of subjects: 151

Group type: COMPARATOR
Intervention: Supervised hospital-based exercise, n = 75
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Both treatments (Endovascular revascularization and Supervised exercise)
Number of subjects: 151
Study: 16898305

Group type: EXPERIMENTAL
Intervention: Laryngeal tube (LT) VBM
Number of subjects: 40

Group type: COMPARATOR
Intervention: Laryngeal mask airway (LMA)
Number of subjects: 40
Study: 14722167

Group type: EXPERIMENTAL
Intervention: Remifentanil 0.25 micro g kg(‐1) min(‐1)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Remifentanil 1.0 micro g kg(‐1) min(‐1) and greater
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 49
Study: 12014765

Group type: EXPERIMENTAL
Intervention: Intraumbilical injection of 301U oxytocin in 27mls saline
Number of subjects: 35

Group type: COMPARATOR
Intervention: 0.9% sodium chloride (placebo) 30mls
Number of subjects: 35
Study: 9783759

Group type: EXPERIMENTAL
Intervention: Oral iloprost 50 microg
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Oral iloprost 100 microg
Number of subjects: 103

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 103
Study: 7869062

Group type: EXPERIMENTAL
Intervention: Falls in patients with a history of falling
Number of subjects: 82

Group type: COMPARATOR
Intervention: Patients with no history of falling (Control)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Falls associated with injuries
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Falls frequency
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Risk factors for falling
Number of subjects: 82
Study: 2494024

Group type: EXPERIMENTAL
Intervention: Formal support program
Number of subjects: 94

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 94
Study: 5507464

Group type: EXPERIMENTAL
Intervention: Electrical stimulation of the calf muscles
Number of subjects: 110

Group type: COMPARATOR
Intervention: Unstimulated legs (control)
Number of subjects: 110
Study: 31257996

Group type: EXPERIMENTAL
Intervention: Transfemoral approach (TFA)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Transradial approach (TRA)
Number of subjects: 101
Study: 28990173

Group type: EXPERIMENTAL
Intervention: Rituximab 500 mg/m2 every 2 weeks (for males)
Number of subjects: 268

Group type: COMPARATOR
Intervention: Rituximab 375 mg/m2 (for females)
Number of subjects: 268

Group type: COMPARATOR
Intervention: Standard rituximab schedule
Number of subjects: 268

Group type: COMPARATOR
Intervention: Upfront dose-dense rituximab schedule
Number of subjects: 268
Study: 27128218

Group type: EXPERIMENTAL
Intervention: Lorazepam 2 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: AZD6280 10 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: AZD6280 40 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: AZD7325 2 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: AZD7325 10 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 23979737

Group type: EXPERIMENTAL
Intervention: PA-824 50 mg in fed state
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: PA-824 200 mg in fed state
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: PA-824 1000 mg in fed state
Number of subjects: 48

Group type: COMPARATOR
Intervention: PA-824 50 mg in fasted state
Number of subjects: 48

Group type: COMPARATOR
Intervention: PA-824 200 mg in fasted state
Number of subjects: 48

Group type: COMPARATOR
Intervention: PA-824 1000 mg in fasted state
Number of subjects: 48
Study: 21331567

Group type: EXPERIMENTAL
Intervention: Intravenous ZOL 5 mg yearly
Number of subjects: 2127

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2127
Study: 19844108

Group type: EXPERIMENTAL
Intervention: Geranylgeranylacetone (GGA) 300 mg/day
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 17946174

Group type: EXPERIMENTAL
Intervention: Home telehealth program
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: VALUE program technology
Number of subjects: 0
Study: 15530193

Group type: EXPERIMENTAL
Intervention: Itraconazole (10 mg/kg orally or through a gastric tube)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Fluconazole (10 mg/kg orally or through a gastric tube)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Itraconazole
Number of subjects: 43

Group type: COMPARATOR
Intervention: Fluconazole
Number of subjects: 43
Study: 11354864

Group type: EXPERIMENTAL
Intervention: LCS total knee replacement without resurfacing of the patella
Number of subjects: 436
Study: 9024026

Group type: EXPERIMENTAL
Intervention: Intrathecal sufentanil (ITS) 10 micrograms diluted in 1, 2, or 3 mL of normal saline
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Intrathecal sufentanil (ITS)
Number of subjects: 45
Study: 8515849

Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 0

Group type: COMPARATOR
Intervention: Propofol+fentanyl
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Volume expansion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Postoperative analgesia inadequacy
Number of subjects: 0
Study: 2871744

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 269

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 269
Study: 31647564

Group type: EXPERIMENTAL
Intervention: SMS text‐delivered scheduled gradual reduction (SGR) program plus support texts
Number of subjects: 314

Group type: COMPARATOR
Intervention: SMS support messages alone
Number of subjects: 314
Study: 28830693

Group type: EXPERIMENTAL
Intervention: ZOSTAVAX™ (ZV) and quadrivalent inactivated influenza vaccine (IIV4) administered concomitantly
Number of subjects: 882

Group type: COMPARATOR
Intervention: Quadrivalent inactivated influenza vaccine (IIV4) administered sequentially
Number of subjects: 882
Study: 27143689

Group type: EXPERIMENTAL
Intervention: Docetaxel treatment with SNP analysis
Number of subjects: 623

Group type: EXPERIMENTAL
Intervention: VAC14 SNP (rs875858)
Number of subjects: 623

Group type: EXPERIMENTAL
Intervention: siRNA knockdown of VAC14 in stem cell-derived peripheral neuronal cells
Number of subjects: 623

Group type: COMPARATOR
Intervention: VAC14 heterozygous mice
Number of subjects: 623
Study: 24144627

Group type: EXPERIMENTAL
Intervention: GLP‐1 (7‐36) amide infusion (1.5 pmol/kg/min)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study: 22606064

Group type: EXPERIMENTAL
Intervention: Aloe vera cream (n = 32), applied 3 times a day for 10 days
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Calendula officinalis ointment (n = 34), applied 3 times a day for 10 days
Number of subjects: 66
Study: 20605073

Group type: EXPERIMENTAL
Intervention: Nicotine replacement therapy (NRT)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Counseling calls
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Print materials
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Helpful materials
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Goal setting
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Meeting goals
Number of subjects: 64